Epigral Profit & Loss Annual

Trade
BSE: 543332 | NSE: MFL | ISIN: INE071N01016 | Sector: Chemical Manufacturing
1,851.60 +15.55 (0.85%)Updated : 28 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,929.192,188.401,550.94828.60
Total Revenue 1,929.192,188.401,550.94828.60
Costof Revenue Total 1,220.941,290.43842.46416.92
Gross Profit 708.25897.97708.48411.68
Selling/ General/ Admin Expenses Total 127.16115.6694.0958.31
Depreciation/ Amortization 123.56108.9585.9173.54
Other Operating Expenses Total 99.1990.84104.8392.04
Total Operating Expense 1,570.851,605.881,127.29640.81
Operating Income 358.34582.52423.65187.79
Interest Inc( Exp) Net- Non- Op Total -56.68-44.65-27.05-28.38
Gain( Loss)on Saleof Assets -0.050.00-0.070.00
Other Net -10.86-15.40-13.101.45
Net Income Before Taxes 290.75522.46383.42160.86
Provisionfor Income Taxes 94.88169.17130.6460.02
Net Income After Taxes 195.87353.29252.79100.84
Net Income Before Extra Items 195.87353.29252.79100.84
Net Income 195.87353.29252.79100.84
Income Availableto Com Excl Extra Ord 195.87353.29252.79100.84
Income Availableto Com Incl Extra Ord 195.87353.29252.79100.84
Diluted Net Income 195.87353.29252.79100.84
Diluted Weighted Average Shares 4.164.164.164.16
Diluted EPS Excluding Extra Ord Items 47.1485.0360.8424.27
DPS- Common Stock Primary Issue 5.005.00--
Diluted Normalized EPS 47.1585.0360.8524.27
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,368.50+68.45(5.27%)
142.05+3.35(2.42%)
1,549.40-29.90 (-1.89%)
12,108.25-127.95 (-1.05%)